# Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

> **NCT00130923** · PHASE4 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Schizophrenia
- Psychotic Disorders
- Substance Abuse
- Alcohol Abuse

## Interventions

- **DRUG:** Risperidone Long Acting
- **DRUG:** oral risperidone

## Key facts

- **NCT ID:** NCT00130923
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-06
- **Final completion:** 2010-07
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130923, "Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00130923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*